Ditan

From WikiMD's WELLNESSPEDIA


Overview[edit]

Lasmiditan is a medication used for the acute treatment of migraines with or without aura in adults. It belongs to a class of drugs known as serotonin receptor agonists, specifically targeting the 5-HT1F receptor. Unlike other migraine medications, lasmiditan does not cause vasoconstriction, making it a suitable option for patients with cardiovascular risk factors.

Mechanism of Action[edit]

Lasmiditan is a selective agonist of the 5-HT1F receptor, which is a subtype of the serotonin receptor. By activating this receptor, lasmiditan helps to inhibit the release of pro-inflammatory neuropeptides and reduce the transmission of pain signals in the trigeminal system. This action helps alleviate the symptoms of a migraine attack.

Pharmacokinetics[edit]

Lasmiditan is administered orally and is rapidly absorbed, with peak plasma concentrations occurring approximately 1.8 hours after dosing. It is metabolized primarily by non-CYP enzymes and is excreted mainly in the urine. The half-life of lasmiditan is approximately 5.7 hours, allowing for effective relief of migraine symptoms.

Clinical Use[edit]

Lasmiditan is indicated for the acute treatment of migraine attacks. It is not intended for the preventive treatment of migraines. Patients are advised to take lasmiditan as soon as possible after the onset of migraine symptoms. The recommended dose is 50 mg, 100 mg, or 200 mg, depending on the severity of the migraine and the patient's response to the medication.

Side Effects[edit]

Common side effects of lasmiditan include dizziness, fatigue, paresthesia, and somnolence. Due to its central nervous system effects, patients are advised not to drive or operate heavy machinery for at least 8 hours after taking lasmiditan.

Contraindications[edit]

Lasmiditan is contraindicated in patients with hypersensitivity to the drug or any of its components. Caution is advised in patients with severe hepatic impairment, as the pharmacokinetics of lasmiditan may be altered.

Related Pages[edit]

Gallery[edit]

Chemical structure of Lasmiditan

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Ditan&oldid=6291700"